Erythropoietin for neuroprotection in preterm infants: A longitudinal randomized trial
Not Applicable
- Conditions
- Health Condition 1: P073- Preterm [premature] newborn [other]
- Registration Number
- CTRI/2024/06/068517
- Lead Sponsor
- Mahatma gandhi medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
preterm less than 32 weeks
Exclusion Criteria
1.Genetically defined disorder
2.Severe congenital malformation unfavorably affecting life span
3.Severe congenital malformation unfavorably affecting neurodevelopment
4. A priory palliative care
5. Intracranial haemorrhage grade 3 or more noticed before dose of Erythropoietin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method